Clinical Trials Insight: 700033367
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2008
At a glance
- Drugs NU 172 (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Nuvelo
- 04 Jun 2008 Status changed from planning to recruiting according to Nuvelo media release.
- 04 Jun 2008 Enrollment has begun according to Nuvelo media release.
- 08 May 2008 This trial is expected to be completed and top-line data presented in the third quarter of 2008, reported by Nuvelo.